Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

PJPS. 2024; 12(2): 0-0


ROLE OF TRANEXAMIC ACID IN INTRAOPERATIVE BLOOD LOSS AND POSTOPERATIVE EDEMA AND ECCHYMOSIS IN PRIMARY ELECTIVE RHINOPLASTY: A RANDOMIZED CONTROLLED TRIAL

Muhammad Raza Tahir,Farrukh Aslam Khalid,Muhammad Amin,Maruf Zahid,Rida Naeem,Hafsa Khalid,Kamran Khalid.




Abstract

Objective: To compare blood loss during surgery, edema, and ecchymosis after surgery in patients administered with tranexamic acid (TXA) and normal saline undergoing primary elective rhinoplasty.
Methodology: Sixty-eight patients were included in this randomized control trial (RCT) study presented for rhinoplasty. Thirty-four patients received TXA 20 ml preoperatively while thirty-four received 0.9% normal saline. Outcomes between both groups were assessed in terms of surgery duration, intraoperative bleeding, edema, and ecchymosis between both groups.
Results: All the patients completed the study. The mean age in group A was 33.59±9.25 years while 31.21±9.22 years in group B. The duration of surgery in group A turned out to be 103.38±10.37 mins while in group B it was 120±11.31 mins with notably reduced duration of surgery in group B (P = 0.0001). Group A showed notably lower intraoperative blood loss 148.88±30.75 ml as compared to the placebo group which received normal saline 180.44±24.75 ml (P = 0.0001). The incidence of postoperative edema and ecchymosis compared to the placebo group is significantly lower.
Conclusion: Preoperative tranexamic acid lowers postoperative side effects such as edema and ecchymosis and greatly reduces blood loss in patients undergoing rhinoplasty.

Key words: Rhinoplasty, Edema, Blood loss, Tranexamic acid, Ecchymosis






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.